385224003: Powder for conventional release suspension for injection (dose form)

SNOMED CT Concept\Qualifier value\Pharmaceutical dose form\Parenteral dose form\Powder for conventional release suspension for injection

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Jun 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

2647451016 Powder for suspension for injection en Synonym Active Entire term case insensitive SNOMED CT core module

3620910017 Powder for conventional release suspension for injection (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3620911018 Powder for conventional release suspension for injection en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Powder for conventional release suspension for injection	Is a	Type of drug preparation	false	Inferred relationship	Existential restriction modifier
Powder for conventional release suspension for injection	Is a	Drug powder	false	Inferred relationship	Existential restriction modifier
Powder for conventional release suspension for injection	Is a	Powder for reconstitution for drug product	false	Inferred relationship	Existential restriction modifier
Powder for conventional release suspension for injection	Is a	Injection	false	Inferred relationship	Existential restriction modifier
Powder for conventional release suspension for injection	Is a	Injection powder	false	Inferred relationship	Existential restriction modifier
Powder for conventional release suspension for injection	Is a	Parenteral dose form	true	Inferred relationship	Existential restriction modifier
Powder for conventional release suspension for injection	Has dose form administration method	Inject	true	Inferred relationship	Existential restriction modifier
Powder for conventional release suspension for injection	Has dose form transformation	Disperse	true	Inferred relationship	Existential restriction modifier
Powder for conventional release suspension for injection	Has dose form intended site	Parenteral	true	Inferred relationship	Existential restriction modifier
Powder for conventional release suspension for injection	Has dose form release characteristic	Conventional release	true	Inferred relationship	Existential restriction modifier
Powder for conventional release suspension for injection	Has basic dose form	Powder	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Lyophilized powder for conventional release suspension for injection	Is a	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Powder for prolonged-release suspension for injection	Is a	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Lyophilized powder for prolonged-release suspension for injection	Is a	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Lyophilized powder for conventional release liposomal suspension for injection	Is a	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Leuprolide acetate 7.5mg powder for injection suspension vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Leuprolide acetate 30mg powder for injection suspension vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Leuprolide acetate 11.25mg powder for injection suspension vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Leuprolide acetate 22.5mg powder for injection suspension vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Olanzapine 300mg powder for injection suspension	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Olanzapine 210mg powder for injection suspension	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Olanzapine 405mg powder for injection suspension	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Leuprolide acetate 45mg powder for injection suspension vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely paclitaxel 100 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely galactose 2.49 gram and palmitic acid 2.5 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely galactose 3.99 gram and palmitic acid 4 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely lanreotide (as lanreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely octreotide (as octreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely risperidone 12.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely risperidone 50 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely benzathine benzylpenicillin 1.2 million unit/1 vial powder for conventional release suspension for injection (clinical drug)	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely benzathine benzylpenicillin 2.4 million unit/1 vial powder for conventional release suspension for injection (clinical drug)	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely triptorelin (as triptorelin pamoate) 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely leuprorelin acetate 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug)	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely leuprorelin acetate 7.5 milligram/1 syringe powder for conventional release suspension for injection (clinical drug)	Has manufactured dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 150mg powder for suspension for injection vials	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Accord Healthcare Ltd) 1 vial	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Accord Healthcare Ltd)	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 150mg powder for suspension for injection vials 1 vial	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 150mg powder for suspension for injection vials (Accord Healthcare Ltd)	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 150mg powder for suspension for injection vials (Accord Healthcare Ltd) 1 vial	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd) 1 vial	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Kent Pharma (UK) Ltd)	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Dr Reddy's Laboratories (UK) Ltd)	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Dr Reddy's Laboratories (UK) Ltd) 1 vial	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Tillomed Laboratories Ltd)	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Tillomed Laboratories Ltd) 1 vial	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Sandoz Ltd) 1 vial	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Sandoz Ltd)	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Seacross Pharmaceuticals Ltd)	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Seacross Pharmaceuticals Ltd) 1 vial	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Zentiva Pharma UK Ltd) 1 vial	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Zentiva Pharma UK Ltd)	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Viatris UK Healthcare Ltd) 1 vial	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Azacitidine 100mg powder for suspension for injection vials (Viatris UK Healthcare Ltd)	Has dispensed dose form	True	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Benzathine benzylpenicillin 2.4million unit powder and solvent for suspension for injection vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Octreotide 10mg powder and solvent for injection suspension vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Octreotide 20mg powder and solvent for injection suspension vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Octreotide 30mg powder and solvent for injection suspension vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Leuprolide acetate 3.75mg powder for injection solution + diluent	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Leuprolide acetate 11.25mg injection powder for injection solution + diluent	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Triptorelin 4.2mg powder and solvent for injection suspension vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Rabies inactivated vaccine powder and solvent for injection solution vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Yellow fever live vaccine injection solution vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Galactose microparticles 3996mg/palmitic acid 4mg powder and solvent for injection suspension vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Triptorelin 3.75mg powder and solvent for injection prefilled syringe	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Triptorelin 15mg powder and dilutent for injection	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Risperidone 37.5mg powder and solvent for suspension for injection vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Risperidone 50mg powder and solvent for suspension for injection vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Risperidone 25mg powder and solvent for suspension for injection vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Diphtheria (adsorbed) / Tetanus / Pertussis (acellular) vaccine injection pre-filled syringes and Haemophilus type b conjugate vaccine injection vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Meningococcal C conjugate vaccine powder and solvent for suspension for injection 0.5ml vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Varicella vaccine (live) powder and solvent for suspension for injection 0.5ml vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
BCG vaccine powder and solvent for suspension for injection vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Benzathine benzylpenicillin 600,000unit powder and solvent for suspension for injection vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Benzathine benzylpenicillin 1.2million unit powder and solvent for suspension for injection vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Spectinomycin 2g powder and solvent for suspension for injection vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Spectinomycin 2g powder and solvent for suspension for injection vials 1 vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Trobicin 2g powder and solvent for suspension for injection vials (Pharmacia Ltd)	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Trobicin 2g powder and solvent for suspension for injection vials (Pharmacia Ltd) 1 vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Procaine benzylpenicillin 1.2million unit powder and solvent for suspension for injection vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Procaine benzylpenicillin 1.2million unit powder and solvent for suspension for injection vials 1 vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Farmaproina 1.2million unit powder and solvent for suspension for injection vials (Reig Jofre Laboratory)	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Farmaproina 1.2million unit powder and solvent for suspension for injection vials (Reig Jofre Laboratory) 1 vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Procaine benzylpenicillin 600,000unit powder and solvent for suspension for injection vials	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Procaine benzylpenicillin 600,000unit powder and solvent for suspension for injection vials 1 vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Farmaproina 600,000unit powder and solvent for suspension for injection vials (Reig Jofre Laboratory)	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Farmaproina 600,000unit powder and solvent for suspension for injection vials (Reig Jofre Laboratory) 1 vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Risperdal Consta 37.5mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd)	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Risperdal Consta 50mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd)	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Risperdal Consta 37.5mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) 1 vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Risperdal Consta 50mg powder and solvent for suspension for injection vials (PI) (Waymade Ltd) 1 vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Octreotide 10mg powder and solvent for injection suspension vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier
Octreotide 20mg powder and solvent for injection suspension vial	Has manufactured dose form	False	Powder for conventional release suspension for injection	Inferred relationship	Existential restriction modifier

Page 1 of 3 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2647451016	Powder for suspension for injection	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3620910017	Powder for conventional release suspension for injection (dose form)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3620911018	Powder for conventional release suspension for injection	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module